Literature DB >> 28979394

The incidence of intensive care unit-acquired weakness syndromes: A systematic review.

Richard Td Appleton1, John Kinsella2, Tara Quasim2.   

Abstract

We conducted a literature review of the intensive care unit-acquired weakness syndromes (critical illness polyneuropathy, critical illness myopathy and critical illness neuromyopathy) with the primary objective of determining their incidence as a combined group. Studies were identified through MEDLINE, Embase, Cochrane Database and article reference list searches and were included if they evaluated the incidence of one or more of these conditions in an adult intensive care unit population. The incidence of an intensive care unit-acquired weakness syndrome in the included studies was 40% (1080/2686 patients, 95% confidence interval 38-42%). The intensive care unit populations included were heterogeneous though largely included patients receiving mechanical ventilation for seven or more days. Additional prespecified outcomes identified that the incidence of intensive care unit-acquired weakness varied with the diagnostic technique used, being lower with clinical (413/1276, 32%, 95% CI 30-35%) compared to electrophysiological techniques (749/1591, 47%, 95% CI 45-50%). Approximately a quarter of patients were not able to comply with clinical evaluation and this may be responsible for potential underreporting of this condition.

Entities:  

Keywords:  Critical care; epidemiology; intensive care; intensive care unit-acquired weakness; muscle weakness

Year:  2014        PMID: 28979394      PMCID: PMC5606476          DOI: 10.1177/1751143714563016

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  47 in total

1.  Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator.

Authors:  F S Leijten; A W De Weerd; D C Poortvliet; V A De Ridder; C Ulrich; J E Harink-De Weerd
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

2.  Acquired weakness, handgrip strength, and mortality in critically ill patients.

Authors:  Naeem A Ali; James M O'Brien; Stephen P Hoffmann; Gary Phillips; Allan Garland; James C W Finley; Khalid Almoosa; Rana Hejal; Karen M Wolf; Stanley Lemeshow; Alfred F Connors; Clay B Marsh
Journal:  Am J Respir Crit Care Med       Date:  2008-05-29       Impact factor: 21.405

Review 3.  Neuromuscular sequelae of critical illness.

Authors:  Nicola Latronico; Indrit Shehu; Elisa Seghelini
Journal:  Curr Opin Crit Care       Date:  2005-08       Impact factor: 3.687

4.  Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery'.

Authors:  R I Thiele; H Jakob; E Hund; S Tantzky; S Keller; M Kamler; U Herold; S Hagl
Journal:  Thorac Cardiovasc Surg       Date:  2000-06       Impact factor: 1.827

5.  Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis.

Authors:  M Mohr; L Englisch; A Roth; H Burchardi; S Zielmann
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440

6.  One-year outcomes in survivors of the acute respiratory distress syndrome.

Authors:  Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

7.  Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients.

Authors:  Jose Garnacho-Montero; Rosario Amaya-Villar; Jose Luis García-Garmendía; Juan Madrazo-Osuna; Carlos Ortiz-Leyba
Journal:  Crit Care Med       Date:  2005-02       Impact factor: 7.598

8.  Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients.

Authors:  Steffen Weber-Carstens; Susanne Koch; Simone Spuler; Claudia D Spies; Florian Bubser; Klaus D Wernecke; Maria Deja
Journal:  Crit Care Med       Date:  2009-09       Impact factor: 7.598

9.  Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit.

Authors:  S Nanas; K Kritikos; E Angelopoulos; A Siafaka; S Tsikriki; M Poriazi; D Kanaloupiti; M Kontogeorgi; M Pratikaki; D Zervakis; C Routsi; C Roussos
Journal:  Acta Neurol Scand       Date:  2008-03-18       Impact factor: 3.209

10.  Signs of critical illness polyneuropathy and myopathy can be seen early in the ICU course.

Authors:  K Ahlbeck; K Fredriksson; O Rooyackers; G Måbäck; S Remahl; T Ansved; L Eriksson; P Radell
Journal:  Acta Anaesthesiol Scand       Date:  2009-04-14       Impact factor: 2.105

View more
  28 in total

1.  Intensive care unit-acquired weakness: A review from molecular mechanisms to its impact in COVID-2019.

Authors:  Andrea Gonzalez; Johanna Abrigo; Oscar Achiardi; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Eur J Transl Myol       Date:  2022-08-26

Review 2.  Early Mobilization and Rehabilitation of Patients Who Are Critically Ill.

Authors:  Mohamed D Hashem; Ann M Parker; Dale M Needham
Journal:  Chest       Date:  2016-03-18       Impact factor: 9.410

3.  Recommendations for Hospital-Based Physical Therapists Managing Patients With COVID-19.

Authors:  Karin M Felten-Barentsz; Roel van Oorsouw; Emily Klooster; Niek Koenders; Femke Driehuis; Erik H J Hulzebos; Marike van der Schaaf; Thomas J Hoogeboom; Philip J van der Wees
Journal:  Phys Ther       Date:  2020-08-31

Review 4.  Rehabilitation and early mobilization in the critical patient: systematic review.

Authors:  Patricia Arias-Fernández; Macarena Romero-Martin; Juan Gómez-Salgado; Daniel Fernández-García
Journal:  J Phys Ther Sci       Date:  2018-09-04

5.  Repetitive vascular occlusion stimulus (RVOS) versus standard care to prevent muscle wasting in critically ill patients (ROSProx):a study protocol for a pilot randomised controlled trial.

Authors:  Ismita Chhetri; Julie E A Hunt; Jeewaka R Mendis; Stephen D Patterson; Zudin A Puthucheary; Hugh E Montgomery; Benedict C Creagh-Brown
Journal:  Trials       Date:  2019-07-24       Impact factor: 2.279

6.  Safety, Feasibility, and Efficacy of Early Rehabilitation in Patients Requiring Continuous Renal Replacement: A Quality Improvement Study.

Authors:  Kirby P Mayer; Amanda R Hornsby; Victor Ortiz Soriano; Timothy C Lin; Jennifer T Cunningham; Hanwen Yuan; Caroline E Hauschild; Peter E Morris; Javier A Neyra
Journal:  Kidney Int Rep       Date:  2019-10-11

7.  The Stanford Hall consensus statement for post-COVID-19 rehabilitation.

Authors:  Robert M Barker-Davies; Oliver O'Sullivan; Kahawalage Pumi Prathima Senaratne; Polly Baker; Mark Cranley; Shreshth Dharm-Datta; Henrietta Ellis; Duncan Goodall; Michael Gough; Sarah Lewis; Jonathan Norman; Theodora Papadopoulou; David Roscoe; Daniel Sherwood; Philippa Turner; Tammy Walker; Alan Mistlin; Rhodri Phillip; Alastair M Nicol; Alexander N Bennett; Sardar Bahadur
Journal:  Br J Sports Med       Date:  2020-05-31       Impact factor: 13.800

Review 8.  Dehydroepiandrosterone: a potential therapeutic agent in the treatment and rehabilitation of the traumatically injured patient.

Authors:  Conor Bentley; Jon Hazeldine; Carolyn Greig; Janet Lord; Mark Foster
Journal:  Burns Trauma       Date:  2019-08-02

9.  Acute skeletal muscle wasting and dysfunction predict physical disability at hospital discharge in patients with critical illness.

Authors:  Kirby P Mayer; Melissa L Thompson Bastin; Ashley A Montgomery-Yates; Amy M Pastva; Esther E Dupont-Versteegden; Selina M Parry; Peter E Morris
Journal:  Crit Care       Date:  2020-11-04       Impact factor: 9.097

Review 10.  Intensive Care Unit-Acquired Weakness: Not just Another Muscle Atrophying Condition.

Authors:  Heta Lad; Tyler M Saumur; Margaret S Herridge; Claudia C Dos Santos; Sunita Mathur; Jane Batt; Penney M Gilbert
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.